311,915 research outputs found
Going Beyond Counting First Authors in Author Co-citation Analysis
The present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation
counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings
are based, and we compare ACA results based on two different types of co-citation counting - the traditional type that
only counts the first one among a cited work's authors on the one hand and a non-traditional type that takes into
account the first 5 authors of a cited work on the other hand. Results indicate that the picture produced through this non-traditional author co-citation counting contains more coherent author groups and is therefore considerably clearer. However, this picture represents fewer specialties in the research field being studied than that produced through the traditional first-author co-citation counting when the same number of top-ranked authors is selected and analyzed. Reasons for these effects are discussed
Dispelling the Myths Behind First-author Citation Counts
We conducted a full-scale evaluative citation analysis study of scholars in the XML research field to explore just how different from each other author rankings resulting from different citation counting methods actually are, and to demonstrate the capability of emerging data and tools on the Web in supporting more realistic citation counting methods. Our results contest some common arguments for the continued
use of first-author citation counts in the evaluation of scholars, such as high correlations between author rankings by first-author citation counts and other citation
counting methods, and high costs of using more realistic citation counting methods that are not well-supported by the ISI databases. It is argued that increasingly available digital full text research papers make it possible for citation analysis studies to go beyond what the ISI databases have directly supported and to employ more
sophisticated methods
Samuel Swinton Jacob e il Jeypore Portfolio: considerazioni sulla documentazione in architettura.
Il saggio [i] illustra l’opera di Sir Samuel Swinton Jacob, una figura rilevante dell’epoca coloniale, che fu profondamente coinvolto, come architetto, nel revival dell’architettura tradizionale indiana nello Stato di Jeypore (ora Jaipur) durante il primo periodo del XIX secolo. In particolare il focus è sul Catalogo dei dettagli architettonici di Jeypore che è costituito dalla raccolta di una serie di rilievi compiuti dallo stesso Jacob. Il saggio esamina il contesto in cui il Catalogo è stato prodotto e la sua influenza sulle costruzioni tradizionali. Inoltre si evidenzia l’evoluzione del concetto di documentazione in India e le sue implicazioni culturali. [i] Questo saggio è un estratto della tesi di Master di Vanicka Arora
Author, publisher and bookseller : a tripartite synergy in Nigerian book industry
This work is about the roles of Author, Publisher and Bookseller in Book development in
Nigeria. The paper started by delving into the history of Book Publishing in Nigeria after
which it proceeded by defining who an author, a publisher, and a bookseller is and
expatiated on the indispensable roles of these key actors in Nigerian Book Industry and in
the emerging Information Society. Furthermore, the various constraints to book
development were identified while the paper advised on how the Book Industry can be
further promoted in Nigeria. However, the paper concluded and made recommendations
on how the Book sector can help in enhancing scholarship in the country
Replikation von Diener, E., Ng, W., Harter, J., & Arora, R. (2010) an der Universität Wien
Es handelt sich bei der Studie um eine Replikation von einer Studie von Diener, E., Ng, W., Harter, J., & Arora, R. (2010). Zusätzlich wurden innerhalb eines Seminars an der Universität Wien, verschiedene Studien diskutiert, von denen schlussendlich eine ausgewählt wurde, aus der eine zusätzliche Hypothese abgeleitet wurde
A Breath of Fresh Air? Firm Type, Scale, Scope, and Selection Effects in Drug Development
This paper compares the innovation performance of established pharmaceutical firms and biotech companies, controlling for differences in the scale and scope of research. We develop a structural model to analyze more than 3,000 drug research and development projects advanced to preclinical and clinical trials in the United States between 1980 and 1994. Key to our approach is careful attention to the issue of selection. Firms choose which compounds to advance into clinical trials. This choice depends not only on the technical promise of the compound, but also on commercial considerations such as the expected profitability of the market or concerns about product cannibalization. After controlling for selection, we find that (a) even after controlling for scale and scope in research, established pharmaceutical firms are more innovative than newly entered biotech firms; (b) older biotech firms display selection behaviors and innovation performances similar to established pharmaceutical firms; and (c) compounds licensed during preclinical trials are as likely to succeed as internal compounds of the licensor, which is inconsistent with the "lemons" hypothesis in technology markets.firm capabilities, drug development process, market for technology
[Report to Chief J. E. Curry, by an unknown author #2]
Report to Chief J. E. Curry, by an unknown author. The report contains a list of officers who gave depositions to the United States Attorney
[Report to Chief J. E. Curry, by an unknown author #1]
Report to Chief J. E. Curry, by an unknown author. The report contains a list of officers who gave depositions to the United States Attorney
- …
